Pharma

Your Article Summary

See Latest Articles

Valeant pharmaceuticals appoints steve stefano of glaxosmithkline to fill board vacancy
Valeant Pharmaceuticals International, 04/01/09

Valeant Pharmaceuticals International announced the appointment of Steve Stefano to its Board of Directors. Mr. Stefano was appointed to fill a vacant board position with a term that expires at the 2010 Annual Stockholders Meeting. Mr. Stefano's election brings the company's board to nine members. “We are pleased to add someone of Steve’s caliber to our Board,” said J. Michael Pearson, Chairman and Chief Executive Officer. “Given his experience in the managed care area, coupled with his leadership and experience at our partner GlaxoSmithKline, Steve will provide valuable insight and perspective to our already diverse Board.”

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
American Pharmaceutical Partners, 12/03/09

Cardinal Health names Carrie Cox to board of directors
Cardinal Health, 12/03/09

Medtronic Names Michael J. Coyle as Executive Vice President and Group President of Cardiology Businesses
Medtronic, 12/03/09

 See all of Execs on the Move